BioNumerik and Asta to develop BNP7787

BioNumerik (San Antonio, Texas) and Asta Medica Oncology (Brussels, Belgium) will co-develop BioNumerik's BNP7787 chemoprotectant worldwide expect in the U.S., Canada and Japan. Asta will have exclusi...